Business Segments Kintor Pharmaceutical Limited OTC Markets
Stocks
KNTPF
KYG5273B1077
Biotechnology & Medical Research
|
Delayed
OTC Markets
10:46:29 2026-08-12 EDT
|
5-day change | 1st Jan Change | ||
| 0.2399 USD | +39.48% |
|
0.00% | +11.06% |
| 08-19 | Kintor Pharmaceutical Limited Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
| 06-10 | Kintor Pharma Posts Positive Interim Safety Data for Whitening Agent KT-939 | MT |
Sales 2025 by Business Segment
Sales 2025 by Geography
Historical Breakdown of Revenue by Business Segments
Net Income: Breakdown by Business Segment
| Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Biological Products | ||||||||||
cosmetic products and raw materials | 34.23M | - | - | 5M | 32.68M | |||||
Total Assets | 2.07B | 2.06B | 869M | 515M | 341M | |||||
Interest Expense | -2.49M | -8.19M | -9.69M | -9.28M | -3.94M | |||||
Income Tax Expense | - | 1.08M | -8.04M | 18K | -2.85M | |||||
CAPEX | -106M | -27.65M | -2.72M | -1.54M | -742K | |||||
EBT | -842M | -953M | -1.07B | -155M | -203M | |||||
Gross Profit | 34.23M | - | -42.23M | -4.73M | 8.04M | |||||
D&A | 10.37M | 18.24M | 18.86M | 17.49M | 33.11M | |||||
Operating Income | -840M | -945M | -1.06B | -145M | -200M | |||||
Net Income | -842M | -954M | -1.06B | -155M | -200M |
Geographical Revenue Distribution History
| Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Overseas | - | - | - | 987K | - | |||||
Others | 4.04M | - | - | - | - | |||||
Mainland China | 30.19M | - | - | 4.01M | - | |||||
Interest Expense | - | - | - | - | - | |||||
Income Tax Expense | - | - | - | - | - | |||||
D&A | - | - | - | - | - | |||||
Total Assets | - | - | - | - | - | |||||
CAPEX | - | - | - | - | - | |||||
Gross Profit | - | - | - | - | - | |||||
Net Income | - | - | - | - | - | |||||
EBT | - | - | - | - | - | |||||
Operating Income | - | - | - | - | - |
Select your edition
All financial news and data tailored to specific country editions
